ReDO_DB: the repurposing drugs in oncology database
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Repurposing is a drug development strategy that seeks to use existing medications for new indications. In oncology, there is an increased level of activity looking at the use of non-cancer drugs as possible cancer treatments. The Repurposing Drugs in Oncology (ReDO) project has used a literature-based approach to identify licensed non-cancer drugs with published evidence of anticancer activity. Data from 268 drugs have been included in a database (ReDO_DB) developed by the ReDO project. Summary results are outlined and an assessment of clinical trial activity also described. The database has been made available as an online open-access resource (http://www.redo-project.org/db/).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DrugBank 5.0: a major update to the DrugBank database for 2018
Wishart, D. S., Feunang, Y. D., Guo, A. C., Lo, E. J., Marcu, A., Grant, J. R., Sajed, T., Johnson, D., Li, C., Sayeeda, Z., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1037 · Cited by 8,404
Repurposing drugs in oncology (ReDO)—Cimetidine as an anti-cancer agent
Pantziarka, P. (2014) · ecancermedicalscience · doi:10.3332/ecancer.2014.485 · Cited by 280
Self-citationTai, L.-H., Zhang, J., Scott, K. J., de Souza, C. T., Alkayyal, A. A., Ananth, A. A., Sahi, S., Adair, R. A., Mahmoud, A. B., Sad, S., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0246 · Cited by 70
Cited by
Utilizing graph machine learning within drug discovery and development
Gaudelet, T., Day, B., Jamasb, A. R., Soman, J., Regep, C., Liu, G., Hayter, J. B. R., Vickers, R., Roberts, C., Tang, J., et al. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab159 · Cited by 313
New drugs are not enough‑drug repositioning in oncology: An update
Armando, R., Mengual G�mez, D., & Gomez, D. (2020) · International Journal of Oncology · doi:10.3892/ijo.2020.4966 · Cited by 90
Halatsch, M.-E., Kast, R. E., Karpel-Massler, G., Mayer, B., Zolk, O., Schmitz, B., Scheuerle, A., Maier, L., Bullinger, L., Mayer-Steinacker, R., et al. (2021) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdab075 · Cited by 74
Self-citationRepurposing drugs in oncology: From candidate selection to clinical adoption
Pantziarka, P., Verbaanderd, C., Huys, I., Bouche, G., & Meheus, L. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.01.008 · Cited by 69
Self-citationDisulfiram and 6-Thioguanine synergistically inhibit the enzymatic activities of USP2 and USP21
Lin, H.-C., Kuan, Y., Chu, H.-F., Cheng, S.-C., Pan, H.-C., Chen, W.-Y., Sun, C.-Y., & Lin, T.-H. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.02.072 · Cited by 24
Metadata
- Authors
- Pantziarka, P., Verbaanderd, C., Sukhatme, V., Capistrano, R., Crispino, S., Gyawali, B., Rooman, I., Van Nuffel, A. M., Meheus, L., Sukhatme, V. P., & Bouche, G.
- Venue
- ecancermedicalscience
- Publisher
- Ecancer Global Foundation
- Published
- 2018-12-06
- Volume
- 12
- Pages
- 886-886
- ISSN
- 1754-6605 (ISSN-L)
- OpenAlex
- W2902166610
- Cited by
- 136
- References
- 3
- FWCI
- 10.30
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: ReDO_DB: the repurposing drugs in oncology database. https://app.cochat.ai/papers/10.3332/ecancer.2018.886
- The paper
- Pantziarka, P., Verbaanderd, C., Sukhatme, V., Capistrano, R., Crispino, S., Gyawali, B., Rooman, I., Van Nuffel, A. M., Meheus, L., Sukhatme, V. P., & Bouche, G. (2018). ReDO_DB: the repurposing drugs in oncology database. ecancermedicalscience. https://doi.org/10.3332/ecancer.2018.886
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.